Establishing Best Treatment Strategy for T4 Esophageal Cancer

NCT06531434 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer TNM Staging Primary Tumor (T) T4

Interventions

COMBINATION_PRODUCT: "Docetaxel", "Cisplatin", "fluorouracil", "Radiation"

Sponsor

National Cheng-Kung University Hospital